ResearcherBoston UniversityActive in the last 2 years
Steve Kwon
Matched on ORCID iD 0000-0002-7321-4347; OpenAlex author ID A5008712511. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2025: 2 papers · 2026: 1 paper
Papers 3
- Exploring the role of adjuvant chemotherapy in older patients with early-stage pancreatic adenocarcinoma. Last author DOI 10.1016/j.jgo.2026.104383↗
- The impact of institutional volume of minimally invasive pancreatic resection on short- and long-term outcomes for pancreatic ductal adenocarcinoma: difference… Last author DOI 10.1016/j.gassur.2025.102230↗
- Relationship of Time to First Therapy and Survival Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery Approach in Resectable Pancreatic Ductal Adenoca… Last author DOI 10.1016/j.jss.2024.12.007↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ponnandai Sadasivan Somasundar · 3 shared papers, 2025–2026 · strength 0.94
- Paper Exploring the role of adjuvant chemotherapy in older patients with early-stage pancreatic adenocarcinoma. DOI 10.1016/j.jgo.2026.104383↗
- Paper The impact of institutional volume of minimally invasive pancreatic resection on short- and long-term outcomes for panc… DOI 10.1016/j.gassur.2025.102230↗
- Paper Relationship of Time to First Therapy and Survival Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery Approach… DOI 10.1016/j.jss.2024.12.007↗
- Madeline Farrar · 1 shared paper, 2026 · strength 0.36
- Omid Salehi · 1 shared paper, 2025 · strength 0.33
- Qusai AlMasad · 1 shared paper, 2025 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.